Target Price | JPY8,060.71 |
Price | JPY6,877.00 |
Potential |
17.21%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target Chugai Pharmaceutical 2026 .
The average Chugai Pharmaceutical target price is JPY8,060.71.
This is
17.21%
register free of charge
JPY11,600.00
68.68%
register free of charge
JPY6,100.00
11.30%
register free of charge
|
|
A rating was issued by 17 analysts: 9 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of
17.21%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,170.61 | 1,204.15 |
5.33% | 2.86% | |
EBITDA Margin | 48.81% | 49.93% |
21.24% | 2.30% | |
Net Margin | 33.09% | 35.71% |
12.96% | 7.92% |
16 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
6 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 235.39 | 261.32 |
18.99% | 11.02% | |
P/E | 26.55 |
6 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.